我們已在上線! 進一步了解
NAII圖示

Natural Alternatives International

1.15 USD
+0.03
2.68%
收盤時 已更新 10月16日 下午4:00 EDT
1天
2.68%
5天
1.77%
1個月
-41.33%
3個月
-49.12%
6個月
-57.25%
今年迄今
-67.97%
1年
-57.25%
5年
-91.42%
10年
-91.61%
 

關於: Natural Alternatives International Inc is formulator, manufacturer and marketer of nutritional supplements. Its comprehensive strategic partnerships with its customers allow to offer a wide range of nutritional products and services to such customers including scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. It has two segments Private-label contract manufacturing, and Patent and trademark licensing. Majority of revenue comes from Private-label contract manufacturing. Majority of revenue comes from United States.

員工: 230

新聞

正面
中性
負面
市場情緒 3個月
正面 33.3%
中性 66.7%
負面 0%
中性
Zacks Investment Research
17 天前
Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure
NAII posts y/y sales growth in Q4'26, but a $10.4M impairment charge and factory underutilization weigh on profitability.
Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure
中性
GlobeNewsWire
18 天前
Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results
CARLSBAD, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced today a net loss of $13.5 million, or ($2.23) per diluted share, on net sales of $34.5 million for the fourth quarter of fiscal year 2026 compared to a net loss of $7.2 million, or ($1.20) per diluted share, in the fourth quarter of the prior fiscal year. Our net loss for the fourth quarter of fiscal 2026 includes a non-recurring non-cash charge of $10.4 million related to the impairment of our Carlsbad, CA manufacturing facility due to its underutilization. Excluding this charge, our net loss for the fourth quarter of fiscal 2026 would have been $3.1 million, or ($0.52) per diluted share.
Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results
正面
Zacks Investment Research
2 個月前
3 Microcaps for Your Watchlist
NHTC, HCWC, and NAII sell into the growing nutrition and wellness space.
3 Microcaps for Your Watchlist
正面
Benzinga
3 個月前
Top 3 Risk Off Stocks That May Rocket Higher In Q3
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Top 3 Risk Off Stocks That May Rocket Higher In Q3
負面
Zacks Investment Research
4 個月前
Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure
NAII's Q3 sales rise 23% y/y, but a wider loss and margin pressure offset gains from stronger contract manufacturing demand.
Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure
中性
GlobeNewsWire
5 個月前
Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results
CARLSBAD, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $4.3 million, or $0.72 per diluted share, on net sales of $35.5 million for the third quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the third quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results
中性
Zacks Investment Research
8 個月前
Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase
NAII posts higher Q2 sales but wider losses, and trims its outlook for fiscal 2026 amid softer customer forecasts and launch delays.
Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase
中性
GlobeNewsWire
8 個月前
Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results
CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.6 million, or $0.42 per diluted share, on net sales of $34.8 million for the second quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the second quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results
正面
Zacks Investment Research
9 個月前
Niche Focus & Regulation Shape the Future of Healthcare Firms
CPIX, NAII and ICCC lean into specialization, compliance and targeted growth to thrive in the niche healthcare markets.
Niche Focus & Regulation Shape the Future of Healthcare Firms
中性
GlobeNewsWire
11 個月前
Natural Alternatives International, Inc. Announces 2026 Q1 Results
CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $0.3 million, or $0.05 per diluted share, on net sales of $37.7 million for the first quarter of fiscal year 2026 compared to a net loss of $2.0 million, or $0.33 per diluted share, in the first quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces 2026 Q1 Results
價格圖表採用Lightweight Charts™實作